Danaher Corp
Close on Oct 30, 2026Market cap $163.25BP/E 41.2Yield –
Danaher Leica Biosystems & Microsystems by Year
Leica Biosystems & Microsystems (Pathology & Microscopy) — FDA 510(k) Clearances
Danaher Leica Biosystems & Microsystems: 0 in FY2025, down 100.0% from a year earlier. That is the lowest of the 9 years on record here.
Where the FY2025 figure comes from
Source: U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗
Reported in U.S. FDA openFDA Device 510(k) Clearances API.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Leica Biosystems & Microsystems (Pathology & Microscopy) — FDA 510(k) Clearances | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | -100.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2024 | Dec 31, 2024 | 1 | 0.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2023 | Dec 31, 2023 | 1 | – | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2022 | Dec 31, 2022 | 0 | – | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2021 | Dec 31, 2021 | 0 | -100.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2020 | Dec 31, 2020 | 1 | 0.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2019 | Dec 31, 2019 | 1 | -50.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2018 | Dec 31, 2018 | 2 | +100.0% | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
| FY2017 | Dec 31, 2017 | 1 | – | U.S. FDA openFDA API (510(k), PMA, Recalls, Enforcement, MAUDE) ↗ |
Cite this data
StockData. (2026). Danaher Leica Biosystems & Microsystems, annual FY2017–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/ext-fda-510k-leica-biosystems
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.